Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Citron

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
Journal of Clinical Microbiology|November 24, 1999
Novel bacterium isolated from a lung transplant patient with cystic fibrosisC Pitulle, D M Citron, B Bochner, et al.
Reviews of Infectious Diseases|January 1, 1979
Cefoxitin for treatment of infections due to anaerobic bacteriaB D Kirby, D F Busch, D M Citron, et al.
Journal of Clinical Microbiology|October 8, 1997
Growth characteristics and a novel method for identification (the WEE-TAB system) of Porphyromonas species isolated from infected dog and cat bite wounds in humansM K Hudspeth, S Hunt Gerardo, D M Citron, et al.
Journal of Clinical Microbiology|February 18, 1998
Evaluation of the RapID CB Plus system for identification of Corynebacterium species and other gram-positive rodsM K Hudspeth, S Hunt Gerardo, D M Citron, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1982
Impact of cefoperazone therapy on fecal floraM E Mulligan, D M Citron, B T McNamara, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1986
Susceptibility of Eikenella corrodens to newer and older quinolonesE J Goldstein, D M Citron, A E Vagvolgyi, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogensE J Goldstein, D M Citron, C V Merriam, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Activities of gemifloxacin (SB 265805, LB20304) compared to those of other oral antimicrobial agents against unusual anaerobesE J Goldstein, D M Citron, C Vreni Merriam, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infectionsE J Goldstein, D M Citron, C V Merriam, et al.
Antimicrobial Agents and Chemotherapy|May 29, 1999
Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infectionsE J Goldstein, D M Citron, C V Merriam, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Journal of Clinical Microbiology|November 24, 1999
Novel bacterium isolated from a lung transplant patient with cystic fibrosisC Pitulle, D M Citron, B Bochner, et al.
Reviews of Infectious Diseases|January 1, 1979
Cefoxitin for treatment of infections due to anaerobic bacteriaB D Kirby, D F Busch, D M Citron, et al.
Journal of Clinical Microbiology|October 8, 1997
Growth characteristics and a novel method for identification (the WEE-TAB system) of Porphyromonas species isolated from infected dog and cat bite wounds in humansM K Hudspeth, S Hunt Gerardo, D M Citron, et al.
Journal of Clinical Microbiology|February 18, 1998
Evaluation of the RapID CB Plus system for identification of Corynebacterium species and other gram-positive rodsM K Hudspeth, S Hunt Gerardo, D M Citron, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1982
Impact of cefoperazone therapy on fecal floraM E Mulligan, D M Citron, B T McNamara, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1986
Susceptibility of Eikenella corrodens to newer and older quinolonesE J Goldstein, D M Citron, A E Vagvolgyi, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogensE J Goldstein, D M Citron, C V Merriam, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Activities of gemifloxacin (SB 265805, LB20304) compared to those of other oral antimicrobial agents against unusual anaerobesE J Goldstein, D M Citron, C Vreni Merriam, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infectionsE J Goldstein, D M Citron, C V Merriam, et al.
Antimicrobial Agents and Chemotherapy|May 29, 1999
Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infectionsE J Goldstein, D M Citron, C V Merriam, et al.
Pageof 12